FeesSafety
Pluang+

Provident Financial Services remains a Buy with strong asset quality and undervalued stock price.

Analyst Insights
26 Oct 2026, 23:21 WIB
Seeking Alpha
View Source
Bullish
Provident Financial Services remains a Buy with strong asset quality and undervalued stock price.

Provident Financial Services, Inc. is rated a Buy due to its strong asset quality, attractive valuation, and ongoing earnings growth. The company has grown its deposit base with low-cost deposits and maintains a net interest margin of 3.48%. Its stock trades near book value with a forward P/E of 9.2, indicating undervaluation. Investors should watch for the upcoming Q3 2026 earnings report and management's comments on interest rate impacts as key factors for future performance.

Provident Financial Services is the subject of this update, providing context for readers. For those tracking financial stocks, here is Pluang's market snapshot as of Oct 27, 2026 03:21 WIB: out of 142 priced Financials-sector US stocks, 76 rose and 66 fell. Notable movers include BMNR at USD 20.91 with a 1-day change of -6.65%, AVAT at USD 1.16 with a 1-day change of -6.07%, and WULF at USD 11.93 with a 1-day change of +5.39%.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
17 minutes ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
17 minutes ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
29 minutes ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
2 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App